Male Sexual Function and Sexual Quality of Life in Polygamous Versus Monogamous Marriages
NCT07783958 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1820
Last updated 2026-08-25
Summary
This web-based comparative cross-sectional survey will assess sexual function, sexual quality of life, psychological status, and marital satisfaction among Egyptian men in monogamous and polygamous marriages. Eligible participants will be married Egyptian men aged 18 years or older who provide electronic informed consent and complete an anonymous Arabic-language questionnaire. The primary outcome will be sexual function measured using the Sexual Health Inventory for Men (SHIM/IIEF-5). Secondary outcomes will include Sexual Quality of Life-Male (SQOL-M), Depression Anxiety Stress Scales-21 (DASS-21), marital satisfaction, and sociodemographic and clinical predictors of impaired sexual function. Data will be analyzed using descriptive, comparative, correlation, and multivariable regression methods.
Conditions
Interventions
- OTHER
-
Monogamous marital structure
Existing marital structure consisting of one current wife at the time of questionnaire completion. This is an observational exposure and is not assigned, modified, or administered by the study team. Participants in this exposure group will complete the same anonymous Arabic-language questionnaire as participants in the polygamous-marriage group.
- OTHER
-
Polygamous marital structure
Existing marital structure consisting of two or more current wives at the time of questionnaire completion. This is an observational exposure and is not assigned, modified, or administered by the study team. Participants in this exposure group will complete the same anonymous Arabic-language questionnaire as participants in the monogamous-marriage group.
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Principal Investigators
-
Abul-fotouh Ahmed, MD · Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-20
- Primary Completion
- 2027-05-31
- Completion
- 2027-08-31
Countries
- Egypt
Study Locations
More Related Trials
-
The Prevalence of Erectile Dysfunction (ED) and ED Related Quality of Life of Diabetic Men
NCT00173134 ·Status: UNKNOWN
-
Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.
NCT04703127 ·Status: UNKNOWN ·Phase: PHASE3
-
Ejaculatory and Orgasmic Dysfunction Registry
NCT06605469 ·Status: RECRUITING
-
The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland
NCT05462171 ·Status: COMPLETED
-
Penile Implant Intraoperative Measurements Planning Chart
NCT05531877 ·Status: UNKNOWN ·Phase: NA
-
Studying the Incidence of Erectile Dysfunction in Patients Complaining of Congenital Penile Curvature
NCT05191199 ·Status: COMPLETED
-
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
NCT00284960 ·Status: COMPLETED
-
Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction
NCT07753720 ·Status: RECRUITING ·Phase: PHASE4
-
Using of Testes' Shocker in Improving Sexual Activity
NCT04662398 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice
NCT01106118 ·Status: COMPLETED
-
Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe
NCT00468637 ·Status: UNKNOWN
-
Daily Avanafil for Erectile Dysfunction
NCT04374994 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.
NCT05787769 ·Status: UNKNOWN ·Phase: NA
-
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
NCT06466369 ·Status: COMPLETED ·Phase: PHASE3
-
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction
NCT07761806 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus
NCT05347329 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
NCT07057011 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction
NCT07642505 ·Status: RECRUITING ·Phase: PHASE4
-
Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome
NCT07563647 ·Status: COMPLETED ·Phase: PHASE4
-
Efficiency of Tadalafil for Management of Female Sexual Dysfunction
NCT05266651 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
NCT06583590 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
NCT02714049 ·Status: TERMINATED ·Phase: PHASE4
-
Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)
NCT05556083 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia
NCT04577040 ·Status: UNKNOWN
-
A Survey of Traditional Medicine Pattern Identification in Patients With Erectile Dysfunction
NCT07487181 ·Status: RECRUITING